Sulphation catalysed by the human cytosolic sulphotransferases - chemical defence or molecular terrorism?

Human & Experimental Toxicology

Volumn 15, Issue 7, 1996, Pages 547-555

  Coughtrie, Michael WH ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

bioactivation; Sulphation; sulphotransferases; xenobiotic metabolism

Indexed keywords

4 NITROPHENOL; ADENOSINE 3' PHOSPHATE 5' PHOSPHOSULFATE; CARCINOGEN; CATECHOLAMINE DERIVATIVE; ESTROGEN; MINOXIDIL; SULFOTRANSFERASE; XENOBIOTIC AGENT;

AMINO ACID SEQUENCE; CARCINOGENESIS; COOKING; DEFENSE MECHANISM; DETOXIFICATION; DRUG METABOLISM; ENZYME SPECIFICITY; GENE MUTATION; HEALTH HAZARD; HUMAN; LIVER CYTOSOL; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SULFATION; XENOBIOTIC METABOLISM;

ANIMALS; BIOTRANSFORMATION; CATALYSIS; CYTOSOL; HUMANS; POLYMORPHISM, GENETIC; SULFATES; SULFOTRANSFERASES; XENOBIOTICS;

EID: 0030054952     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1177/096032719601500701     Document Type: Article

References (62)

1. Jakoby WB, Ziegler DM The enzymes of detoxication. Journal of Biological Chemistry 1990; 265: 20715-20718.
2. Dayer P., Desmeules J., Leeman T., Striberni R. Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalysing debrisoquine 4-hydroxylation (cytochrome P-450 db1/buf1). Biochemical And Biophysical Research Communications 1988; 152: 411-416.
3. Meisheri KD, Johnson GA, Puddington L. Enzymatic and non-enzymatic sulfation mechanisms in the biological actions of minoxidil. Biochemical Pharmacology 1993; 45: 271-279.
4. Miller JA Recent studies on the metabolic-activation of chemical carcinogens. Cancer Research 1994; 54: S1879-S1881.
5. Falany CN Molecular enzymology of human liver cytosolic sulfotransferases. Trends in Pharmacological Science 1991; 12: 255-259.
6. Mulder GJ, Jakoby WB Sulfation. In Conjugation Reactions in Drug Metabolism. Mulder GJ (ed) pp. 107-161 Taylor and Francis, London, 1990.
7. Weinshilboum R., Otterness D. Sulfotransferase enzymes. In Conjugation-Decongjugation Reactions in Drug Metabolism and Toxicity. Kauffman FC (ed) pp. 45-78 Springer-Verlag, Berlin, 1994.
8. Lyle S., Stanczak J., Ng K., Schwartz NB Rat chondrosarcoma ATP sulfurylase and adensosine 5′-phosphosulfate kinase reside on a single bifunctional protein. Biochemistry 1994; 33: 5920-5925.
9. Yamazoe Y., Nagata K., Ozawa S., Kato R. Structural similarity and diversity of sulfotransferases. Chemico-Biological Interactions 1994; 92: 107-117.
10. Dooley TP et al. Mapping of the phenol sulfotransferase gene (STP) to human chromosome 16p12.1-p11.2 and to mouse chromosome 7. Genomics 1993; 18: 440-443.
11. Dooley TP et al. Genomic organization and DNA-sequence of the human catecholamine-sulfating phenol sulfotransferase gene (STM). Biochemical And Biophysical Research Communications 1994; 205: 1325-1332.
12. Aksoy IA et al. Thermolabile phenol sulfotransferase gene (STM) - localization to human-chromosome 16p11.2. Genomics 1994; 23: 275-277.
13. Otterness DM, Mohrenweiser HW, Brandriff BF, Weinshilboum RM Dehydroepiandrosterone sulfotransferase gene (STD): Localization to human chromosome band 19q13.3. Cytogenetics and Cell Genetics 1995; 70: 45-47.
14. Her C. et al. Human estrogen sulfotransferase gene (STE): cloning, structure, and chromosomal localization. Genomics 1995; 29: 16-23.
15. Jarvela IE et al. YAC and cosmid contigs spanning the Batten disease (CLN3) region at 16p12.1-p11.2. Genomics 1995; 29: 478-489.
16. Her CT, Raftogianis R., Weinshilboum R. Human sulfotransferase pharmacogenetics - STP2 gene, structural characterization and chromosomal localization. [Abstract] Clinical Pharmacology & Therapeutics 1996; 59: 216.
17. Chiba H. et al. The 3′-terminal exon of the family of steroid and phenol sulfotransferase genes is spliced at the N-terminal glycine of the universally conserved GXXGXXK motif that forms the sulfonate donor binding site. Proceedings of the National Academy of Sciences USA 1995; 92: 8176-8179.
18. Komatsu K., Driscoll WJ, Koh YC, Strott CA A P-loop related motif (GXXGXXK) highly conserved in sulfotransferases is required for binding the activated sulfate donor. Biochemical And Biophysical Research Communications 1994; 204: 1178-1185.
19. Mizuma T., Komori M., Ueno M., Horikoshi I. Sulphate conjugation enhances reversible binding of drug to human serum albumin. Journal of Pharmacy and Pharmacology 1991; 43: 446-448.
20. Mulder GJ Sulfation in vivo and in isolated intact cell preparations. In Sulfation of Drugs and Other Compounds. Mulder GJ (ed) pp. 131-185 CRC Press, Boca Raton, 1981.
21. Kauffman FC, Whittaker M., Anundi I., Thurman RG Futile cycling of a sulfate conjugate by isolated hepatocytes. Molecular Pharmacology 1991; 39: 414-420.
22. Pesola GR, Walle T. Stereoselective sulfate conjugation of isoproterenol in humans: Comparison of hepatic, intestinal and platelet activity. Chirality 1993; 5: 602-609.
23. Heroux JA, Falany CN, Roth JA Immunological characterization of human phenol sulfotransferase. Molecular Pharmacology 1989; 36: 29-33.
24. Sundaram RS et al. Human intestinal phenol sulfotransferase: Assay conditions, activity levels and partial purification of the thermolabile form. Drug Metabolism And Disposition 1989; 17: 255-264.
25. Pacifici GM, De Santi C., Mussi A., Ageletti CA Interindividual variability in the rate of salbutamol sulphation in the human lung. European Journal of Clinical Pharmacology 1996; 49: 299-303.
26. Ozawa S. et al. Primary structures and properties of two related forms of aryl sulfotransferases in human liver. Pharmacogenetics 1995; 5: S135-S140.
27. Surh YJ, Tannenbaum SR Sulfotransferase-mediated activation of 7,8,9,10-tetrahydro-7-o1,7,8-dihydrodiol, and 7,8,9,10-tetraol derivatives of benzo[a]pyrene. Chemical Research in Toxicology 1995; 8: 693-698.
28. Hobkirk R. Steroid sulfation-current concepts. Trends in Endocrinology and Metabolism 1993; 4: 69-74.
29. Visser TJ Role of sulfation in thyroid hormone metabolism. Chemico-Biological Interactions 1994; 92: 293-303.
30. Barker EV, Hume R., Hallas A., Coughtrie Mwh. Dehydroepiandrosterone sulfotransferase in the developing human fetus—quantitative biochemical and immunological characterization of the hepatic, renal, and adrenal enzymes. Endocrinology 1994; 134: 982-989.
31. Kuss E. The fetoplacental unit of primates. Experimental And Clinical Endocrinology 1994; 102: 135-165.
32. Young WF, Laws ER, Sharbrough FW, Weinshilboum RM Human phenol sulfotransferase: Correlation of brain and platelet activities. Journal of Neurochemistry 1985; 44: 1131-1137.
33. Renskers KJ, Feor KD, Roth JA Sulfation of dopamine and other biogenic amines by human brain phenol sulfotransferase. Journal of Neurochemistry 1980; 34: 1362-1368.
34. Tyce GM et al. Human liver and conjugation of catecholamines. Journal of Laboratory and Clinical Medicine 1987; 109: 532-537.
35. Clarke CL, Adams JB, Wren BG Induction of estrogen sulfotransferase in the human endometrium by progesterone in organ culture. Journal of Clinical Endocrinology And Metabolism 1982; 55: 70-75.
36. Robel P., Baulieu E. Neurosteroids: Biosynthesis and function. Trends in Endocrinology and Metabolism 1994; 5: 1-8.
37. Flood JF, Morley JE, Roberts E. Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it. Proceedings of the National Academy of Science USA 1989; 89: 1567-1571.
38. Falany CN, Kerl EA Sulfation of minoxidil by human liver phenol sulfotransferase. Biochemical Pharmacology 1990; 40: 1027-1032.
39. Kudlacek PE, Clemens DL, Anderson RJ Characterization of recombinant human liver thermolabile phenol sulfotransferase with minoxidil as the substrate. Biochemical And Biophysical Research Communications 1995; 210: 363-369.
40. Buhl AE et al. Minoxidil sulfotransferase activity influences the efficacy of Rogaine® topical solutions (TS)-enzyme studies using scalp and platelets. [Abstract] Journal of Investigative Dermatology 1994; 102: 534.
41. Dooley TP et al. Localization of minoxidil sulfotransferase in rat liver and the outer root sheath of anagen pelage and vibrissa follicles. Journal of Investigative Dermatology 1991; 96: 65-70.
42. Baker CA, Uno H., Johnson GA Minoxidil sulfation in the hair follicle. Skin Pharmacology 1994; 7: 335-339.
43. Garay RP et al. CRE 10904 [2-(-p-fluorophenoxy), 1-(o-hydroxyphenyl)-ethane]: A new diuretic and antihypertensive drug acting by in vivo sulfation. Journal of Pharmacology and Experimental Therapeutics 1990; 255: 415-422.
44. Garay RP et al. Evidence for (+)-cicletanine sulfate as an active natriuretic metabolite of cicletanine in the rat. European Journal of Pharmacology 1995; 274: 175-180.
45. Miller JA Sulfonation in chemical carcinogenesis-history and present status. Chemico-Biological Interactions 1994; 92: 329-341.
46. Boberg EW et al. Strong evidence from studies with brachymorphic mice and pentachlorophenol that 1′-sulfooxysafrole is the major ultimate electrophilic and carcinogenic metabolite of 1'hydroxysafrole in mouse liver. Cancer Research 1983; 43: 5163-5173.
47. Sugahara K., Schwartz NB Defect in 3'phosphoadenosine 5′-phosphosulfate formation in brachymorphic mice. Proceedings of the National Academy of Sciences USA 1979; 76: 6615-6618.
48. Meerman Jhn et al. Sulfation of carcinogenic aromatic hydroxylamines and hydroxamic acids by rat and human sulfotransferases - substrate-specificity, developmental aspects and sex-differences. Chemico-Biological Interactions 1994; 92: 321-328.
49. Nagata K. et al. Isolation and expression of a cDNA encoding a male-specific rat sulfotransferase that catalyzes activation of N-hydroxy-2-acetylaminofluorene. Journal Of Biological Chemistry 1993; 268: 24720-24725.
50. Gilissen Rahj et al. Sulfation of aromatic hydroxamic acids and hydroxylamines by multiple forms of human liver sulfotransferases. Carcinogenesis 1994; 15: 39-45.
51. Chou H-C., Lang NP, Kadlubar FF Metabolic activation of N-hydroxy arylamines and N-hydroxy heterocyclic amines by human sulfotransferase(s). Cancer Research 1995; 55: 525-529.
52. Ozawa S. et al. Activation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-β]pyridine by cDNAexpressed human and rat arylsulfotransferases. Japanese Journal of Cancer Research 1994; 85: 1220-1228.
53. Glatt H. et al. Activation of benzylic alcohols to mutagens by rat and human sulfotransferases expressed in Escherichia coli. European Journal Of Pharmacology 1995; 293: 173-181.
54. Glatt H. et al. Salmonella strains and mammalian cells genetically engineered for expression of sulfotransferases. Toxicology Letters 1995; 82-3: 829-834.
55. Jones AL et al. Human platelet phenolsulfotransferases — cDNA cloning, stable expression in V79 cells and identification of a novel allelic variant of the phenol-sulfating form. Biochemical And Biophysical Research Communications 1995; 208: 855-862.
56. Forbes KJ et al. Human fetal adrenal hydroxysteroid sulphotransferase: cDNA cloning, stable expression in V79 cells and functional characterisation of the expressed enzyme. Molecular And Cellular Endocrinology 1995; 112: 53-60.
57. Jones AL et al. Reduced platelet phenolsulphotransferase activity towards dopamine and 5-hydroxytryptamine in migraine. European Journal Of Clinical Pharmacology 1995; 49: 109-114.
58. Weinshilboum R., Aksoy I. Sulfation pharmacogenetics in humans. Chemico-Biological Interactions 1994; 92: 233-246.
59. Reveley AM, Bonham Carter SM, Reveley MA, Sandler M. A genetic study of platelet phenolsulphotransferase activity in normal and schizophrenic twins. Journal of Psychiatric Research 1982; 17: 303-307.
60. Reiter C., Weinshilboum R. Platelet phenol sulfotransferase activity: Correlation with sulfate conjugation of acetaminophen. Clinical Pharmacology and Therapeutics 1982; 32: 612-621.
61. Aksoy IA, Sochorová V., Weinshilboum RM Human liver dehydroepiandrosterone sulfotransferase-nature and extent of individual variation. Clinical Pharmacology and Therapeutics 1993; 54: 498-506.
62. Wood TC, Otterness DM, Weinshilboum RM Human dehydroepiandrosterone sulfotransferase pharmacogenetics: restriction fragment length polymorphisms and gene sequence polymorphisms. [Abstract] ISSX Proceedings 1995; 8: 111.